The release of Doxorubicin from liposomes monitored by MRI and triggered by a combination of US stimuli led to a complete tumor regression in a breast cancer mouse model-Reference-Cited by-同舟云学术

The release of Doxorubicin from liposomes monitored by MRI and triggered by a combination of US stimuli led to a complete tumor regression in a breast cancer mouse model

Published:2016-05 Issue: Volume:230 Page:57-63
ISSN:0168-3659
Container-title:Journal of Controlled Release
language:en
Short-container-title:Journal of Controlled Release

Author:

Rizzitelli S.,Giustetto P.,Faletto D.,Delli Castelli D.,Aime S.,Terreno E.^ORCID

Funder

University of Torino

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference46 articles.

1. Image guided therapy: the advent of theranostic agents;Terreno;J. Control. Release,2012

2. The upcoming field of theranostic nanomedicine: an overview;Prabhu;J. Biomed. Nanotechnol.,2012

3. Theranostic nanomedicine for cancer;Sumer;Nanomedicine,2008

4. The Chemistry of Contrast Agents in Medical Magnetic Resonance Imaging,2013

5. Drug delivery systems: entering the mainstream;Allen;Science,2004

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Facile NMR Method for Pre‐MRI Evaluation of Trigger‐Responsive T₁ Contrast Enhancement;Small Methods;2024-03-08

2. Stratagems for Breast Cancer Management in the Era of Nanotheranostics;Nanotheranostics for Diagnosis and Therapy;2024

3. Nanotheranostics: Clinical Status, Toxicity, Regulatory Consideration, and Future Prospects;Nanotheranostics for Diagnosis and Therapy;2024

4. Activatable liposomes;Liposomes in Drug Delivery;2024

5. Nanotheranostics: Platforms, Current Applications, and Mechanisms of Targeting in Breast and Prostate Cancers;Journal of Nanotheranostics;2023-08-10